Hisun Pharm Hangzhou Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HISUN PHARM HANGZHOU, and what generic and branded alternatives to HISUN PHARM HANGZHOU drugs are available?
HISUN PHARM HANGZHOU has twenty-one approved drugs.
Drugs and US Patents for Hisun Pharm Hangzhou
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hisun Pharm Hangzhou | SIMVASTATIN | simvastatin | TABLET;ORAL | 206557-002 | Nov 13, 2017 | AB | RX | No | No | See Plans and Pricing | See Plans and Pricing | ||||
Hisun Pharm Hangzhou | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 206061-002 | Nov 23, 2018 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
Hisun Pharm Hangzhou | TELMISARTAN | telmisartan | TABLET;ORAL | 207843-002 | Feb 19, 2019 | DISCN | No | No | See Plans and Pricing | See Plans and Pricing | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.